Literature DB >> 16639559

Genetically modified crops: success, safety assessment, and public concern.

Om V Singh1, Shivani Ghai, Debarati Paul, Rakesh K Jain.   

Abstract

With the emergence of transgenic technologies, new ways to improve the agronomic performance of crops for food, feed, and processing applications have been devised. In addition, ability to express foreign genes using transgenic technologies has opened up options for producing large quantities of commercially important industrial or pharmaceutical products in plants. Despite this high adoption rate and future promises, there is a multitude of concerns about the impact of genetically modified (GM) crops on the environment. Potential contamination of the environment and food chains has prompted detailed consideration of how such crops and the molecules that they produce can be effectively isolated and contained. One of the reasonable steps after creating a transgenic plant is to evaluate its potential benefits and risks to the environment and these should be compared to those generated by traditional agricultural practices. The precautionary approach in risk management of GM plants may make it necessary to monitor significant wild and weed populations that might be affected by transgene escape. Effective risk assessment and monitoring mechanisms are the basic prerequisites of any legal framework to adequately address the risks and watch out for new risks. Several agencies in different countries monitor the release of GM organisms or frame guidelines for the appropriate application of recombinant organisms in agro-industries so as to assure the safe use of recombinant organisms and to achieve sound overall development. We feel that it is important to establish an internationally harmonized framework for the safe handling of recombinant DNA organisms within a few years.

Mesh:

Year:  2006        PMID: 16639559     DOI: 10.1007/s00253-006-0449-8

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  9 in total

Review 1.  Beyond risk. A more realistic risk-benefit analysis of agricultural biotechnologies.

Authors:  Inmaculada de Melo-Martín; Zahra Meghani
Journal:  EMBO Rep       Date:  2008-04       Impact factor: 8.807

Review 2.  Can genetic engineering-based methods for gene function identification be eclipsed by genome editing in plants? A comparison of methodologies.

Authors:  P P Amritha; Jasmine M Shah
Journal:  Mol Genet Genomics       Date:  2021-03-09       Impact factor: 3.291

3.  Transgene-specific and event-specific molecular markers for characterization of transgenic papaya lines resistant to Papaya ringspot virus.

Authors:  Ming-Jen Fan; Shu Chen; Yi-Jung Kung; Ying-Huey Cheng; Huey-Jiunn Bau; Tien-Tsai Su; Shyi-Dong Yeh
Journal:  Transgenic Res       Date:  2009-06-14       Impact factor: 2.788

4.  Determinants of public attitudes to genetically modified salmon.

Authors:  Latifah Amin; Md Abul Kalam Azad; Mohd Hanafy Gausmian; Faizah Zulkifli
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

Review 5.  Genetically modified plants: public and scientific perceptions.

Authors:  Smita Rastogi Verma
Journal:  ISRN Biotechnol       Date:  2013-03-07

6.  DNA-Free Genetically Edited Grapevine and Apple Protoplast Using CRISPR/Cas9 Ribonucleoproteins.

Authors:  Mickael Malnoy; Roberto Viola; Min-Hee Jung; Ok-Jae Koo; Seokjoong Kim; Jin-Soo Kim; Riccardo Velasco; Chidananda Nagamangala Kanchiswamy
Journal:  Front Plant Sci       Date:  2016-12-20       Impact factor: 5.753

Review 7.  Genetic modifications associated with sustainability aspects for sustainable developments.

Authors:  Pooja Sharma; Surendra Pratap Singh; Hafiz M N Iqbal; Roberto Parra-Saldivar; Sunita Varjani; Yen Wah Tong
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

8.  The three main monotheistic religions and gm food technology: an overview of perspectives.

Authors:  Emmanuel B Omobowale; Peter A Singer; Abdallah S Daar
Journal:  BMC Int Health Hum Rights       Date:  2009-08-22

Review 9.  Comparison of regulatory framework of clinical trial with genetically modified organism-containing vaccines in the Europe, Australia, and Switzerland.

Authors:  Jobin Jose; Swathi Pai
Journal:  Clin Exp Vaccine Res       Date:  2021-05-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.